Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial Infarction. Mark, D. B., Hlatky, M. A., Califf, R. M., Naylor, C. D., Lee, K. L., Armstrong, P. W., Barbash, G., White, H., Simoons, M. L., Nelson, C. L., Clapp-Channing, N., Knight, J. D., Harrell, & Topol, E. J. NEJM, 332:1418-1424, 1995.
bibtex   
@article{mar95,
  title = {Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial Infarction},
  volume = {332},
  journal = {NEJM},
  author = {Mark, D. B. and Hlatky, M. A. and Califf, R. M. and Naylor, C. D. and Lee, K. L. and Armstrong, P. W. and Barbash, G. and White, H. and Simoons, M. L. and Nelson, C. L. and {Clapp-Channing}, N. and Knight, J. D. and {Harrell} and Topol, E. J.},
  year = {1995},
  keywords = {cost-effectiveness,cost-analysis,extrapolation-of-survival-curves-to-get-life-expectancy},
  pages = {1418-1424},
  citeulike-article-id = {13264578},
  posted-at = {2014-07-14 14:09:38},
  priority = {0}
}

Downloads: 0